ALFRESA CORPORATION

Alfresa Corporation specializes in the manufacturing and supply of in-vitro diagnostic reagents for military medical operations, serving critical testing and laboratory needs across U.S. Department of Defense installations. Their core expertise lies in the formulation, quality control, and just-in-time delivery of clinical reagents used in infectious disease screening, blood compatibility testing, and point-of-care diagnostics. The company demonstrates deep operational familiarity with military medical logistics, consistently supplying reagents to forward-deployed naval and expeditionary medical facilities in locations such as Iwakuni, Yokosuka, Sasebo, Diego Garcia, and Atsugi. Their technical proficiency includes aseptic manufacturing protocols, cold-chain compliance, and batch traceability systems aligned with FDA and DoD medical supply standards, ensuring stability and reliability under austere conditions. Alfresa Corporation maintains an exclusive and sustained relationship with the Department of Defense, providing mission-critical diagnostic materials to Navy Medical Service Commands and deployed medical units. Their contract pattern reflects a recurring, mission-driven procurement cycle tied to operational readiness, with reagent supplies tailored to the specific diagnostic platforms and pathogen profiles prevalent in each theater. This consistent engagement suggests a trusted, long-term supplier relationship embedded within the DoD’s global medical logistics network. The company’s industry focus is narrowly centered on in-vitro diagnostic substance manufacturing, a high-regulation niche requiring GMP-grade production, validated analytical methods, and stringent shelf-life management. They are positioned as a specialized provider of diagnostic consumables for defense and public health laboratories, with limited activity in surgical supplies or equipment repair, reinforcing their singular focus on clinical reagent production. Alfresa Corporation is structured as an 8H entity headquartered in Yokohama, Japan, with no public certifications listed. Their geographic footprint is international, supporting U.S. military medical infrastructure across the Indo-Pacific region through localized supply chains and responsive logistics coordination. They operate as a niche, high-reliability vendor within the defense healthcare supply ecosystem.